ArticleComputational and structural biotechnology journal2025
Darling (v2.0): Mining disease-related databases for the detection of biomedical entity associations.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Darling is a web application that employs literature mining to detect disease-related biomedical entity associations. Darling can detect sentence-based cooccurrences of biomedical entities such as genes, proteins, chemicals, functions, tissues, diseases, environments, and phenotypes from biomedical literature found in six disease-centric databases. In this version, we deploy additional query channels focusing on COVID-19, GWAS studies, cardiovascular, neurodegenerative, and cancer diseases. Compared to its predecessor, users now have extended query options including searches with PubMed identifiers, disease records, entity names, titles, single nucleotide polymorphisms, or the Entrez syntax. Furthermore, after applying named entity recognition, one can retrieve and mine the relevant literature from recognized terms for a free input text. Term associations are captured in customizable networks which can be further filtered by either term or co-occurrence frequency and visualized in 2D as weighted graphs or in 3D as multi-layered networks. The fetched terms are organized in searchable tables and clustered annotated documents. The reported genes can be further analyzed for functional enrichment using external applications called from within Darling. The Darling databases, including terms and their associations, are updated annually. Darling is available at: https://www.darling-miner.org/.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.